HOME ABOUT GUESTBOOK RECENT CONTENT SUBJECT COLLECTIONS PUBLISH WITH US

PATENTS

Neurobiology of Lipids 'Patents' section alerts you about the patents, patenting ABC, and business ventures on the subject of the Neurobiology of Lipids scope.

Legal notice: 'Patents' page of the Neurobiology of Lipids is provided for educational purpose only. Reference for a patent or a company at length of this page is not an endorsement or approval of a patent or company. The list below does not make a claim to being comprehensive; It is no substitute for your own research, and should not be relied upon for any purpose. Further info is available at the Neurobiology of Lipids disclaimer statement. Please note that we may inadvertently omit certain national/international patents due to a lack of information. If you notice an omission, please let us know. Each citation may include URL links to related articles. To perform your own search of the US Patent and Trademark Office patent database click here.

Document navigation menu and related items:
PATENTS PATENTING ABC PATENTS in NEWS NoL DISCLAIMER USPTO SEARCH NOTEWORTHY



Patents 

Methods for treating, preventing, and reducing the risk of the onset of Alzheimer's disease using an HMG CoA reductase inhibitor
United States Patent  6,472,421 / Wolozin / October 29, 2002

Inventors:  Wolozin; Benjamin (Hinsdale, IL)
Assignee: Nymox Corporation (St. Laurent, CA)
Appl. No.:  190439
Filed:  November 13, 1998

[USPTO Record] [Inventor contact] [Related Articles: 1 | 2 | 3 | 4 | 5 | 6 | 7 ]


Predictive diagnostic for Alzheimer's disease
United States Patent  6,465,195 / Holtzman , et al. / October 15, 2002

Inventors:  Holtzman; David M. (St. Louis, MO); Niven; Anne Fagan (St. Louis, MO)
Assignee: Washington University (St. Louis, MO)
Appl. No.:  753130
Filed:  December 29, 2000

[USPTO Record] [Inventor contact] [Related Articles: 1 | 2 ]


Modulators of expression and function of LRP in Alzheimer's disease
United States Patent 6,447,775 / Strickland , et al. / September 10, 2002

Inventors: Strickland; Dudley K. (Olney, MD); Hyman; Bradley T. (Swampscott, MA); Kounnas; Maria Z. (San Diego, CA); Moir; Robert D. (Boston, MA); Tanzi; Rudolph E. (Hull, MA); Rebeck; G. William (Somerville, MA)
Assignee: The General Hospital Corporation (Boston, MA); American National Red Cross (Falls Church, VA)
Appl. No.: 441063
Filed: November 16, 1999

[USPTO Record] [USPTO Earlier Record] [Inventor contact]


Methods for determining risk of Alzheimer's disease
United States Patent 6,440,387 / Yankner , et al. / August 27, 2002

Inventors: Yankner; Bruce A. (West Newton, MA); Nadeau; Philip (Boston, MA)
Assignee: Children's Medical Center Corporation (Boston, MA)
Appl. No.: 239387
Filed: January 28, 1999

[USPTO Record] [Inventor contact]


Assay to identify compounds that alter apolipoprotein E expression
United States Patent 6,428,950 / Cordell , et al. / August 6, 2002

Inventors: Cordell; Barbara (Palo Alto, CA); Xu; Qiang (Cupertino, CA); Naidu; Asha (Fremont, CA); Paul; Steven M. (Carmel, IN); Bales; Kelly R. (Cloverdale, IN)
Assignee: Scios Inc. (Sunnyvale, CA); Eli Lilly & Co. (Indianapolis, IN)
Appl. No.: 447452
Filed: November 22, 1999

[USPTO Record] [Inventor contact]


Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions and kit related thereto
United States Patent 6,367,479 / Williams / April 9, 2002

Inventors: Williams; Kevin Jon (Wynnewood, PA)
Assignee: Esperion LUV Development, Inc. (Ann Arbor, MI)
Appl. No.: 060642
Filed: April 15, 1998

[USPTO Record] [Inventor contact]


Regulation of the cell cycle by sterols
United States Patent 6,261,760 / Fielding , et al. / July 17, 2001

Inventors: Fielding; Christopher J. (Mill Valley, CA); Fielding; Phoebe E. (Mill Valley, CA)
Assignee: The Regents of The University of California (Oakland, CA)
Appl. No.: 264693
Filed: March 8, 1999

[USPTO Record] [Inventor contact]


Methods for decreasing beta amyloid protein
United States Patent 6,080,778 / Yankner , et al. / June 27, 2000

Inventors: Yankner; Bruce A. (West Newton, MA); Nadeau; Philip (Boston, MA)
Assignee: Children's Medical Center Corporation (Boston, MA)
Appl. No.: 046235
Filed: March 23, 1998

[USPTO Record] [Inventor contact]


Inhibitors of cholesterol esterase
United States Patent 6,034,255 / Deck , et al. / March 7, 2000

Inventors: Deck; Lorraine (Albuquerque, NM); Vander Jagt; David L. (Albuquerque, NM)
Assignee: University of New Mexico (Albuquerque, NM)
Appl. No.: 291990
Filed: April 15, 1999

[USPTO Record] [USPTO Earlier Record] [Inventor contact]


Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis
United States Patent 6,079,416 / Williams / June 27, 2000

Inventors: Williams; Kevin Jon (425 Wister Rd., Wynnewood, PA 19096)
Appl. No.: 060646
Filed: April 15, 1998

[USPTO Record] [Inventor contact]


Methods of regulating CETP genes, enzymes and other compound, and pharmaceutical composition therefor
United States Patent 5,948,435 / Williams / September 7, 1999

Inventors: Williams; Kevin Jon (Wynnewood, PA)
Assignee: Talaria Therapeutics, Inc. (West Conshohocken, PA)
Appl. No.: 850921
Filed: May 2, 1997

[USPTO Record] [Inventor contact]


Method of suppressing a rise in LDL concentrations after administration of an agent having small acceptors
United States Patent 5,858,400 / Williams / January 12, 1999

Inventors: Williams; Kevin Jon (Wynnewood, PA)
Assignee: Talaria Therapeutics, Inc. (West Conshohocken, PA)
Appl. No.: 731257
Filed: October 11, 1996

[USPTO Record] [Inventor contact]


Antemortem diagnostic test for alzheimer's disease
United States Patent 5,631,168 / Growdon , et al. / May 20, 1997

Inventors: Growdon; John H. (Chestnut Hill, MA); Nitsch; Roger M. (Boston, MA); Wurtman; Richard J. (Boston, MA)
Assignee: Massachusetts Institute of Technology (Cambridge, MA)
Appl. No.: 353960
Filed: December 12, 1994

[USPTO Record] [USPTO Earlier Record] [Inventor contact]


Use of coenzyme Q10 in combination with HMG-CoA reductase inhibitor therapies
United States Patent 5,316,765 / Folkers , et al. * / May 31, 1994

Inventors: Folkers; Karl A. (Austin, TX); Langsjoen; Per H. (Temple, TX); Willis; Richard A. (Austin, TX)
Assignee: Karl Folkers Foundation for Biomedical and Clinical Research (Austin, TX)
[*] Notice: The portion of the term of this patent subsequent to January 21, 2009 has been disclaimed.
Appl. No.: 762312
Filed: September 19, 1991

[USPTO Record] [Related Articles: 1 ]


Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
United States Patent 4,595,680 / della Valle , et al. / June 17, 1986

Inventors: della Valle; Francesco (Padua, IT); Romeo; Aurelio (Rome, IT)
Assignee: FIDIA, S.p.A. (Abano Terme, IT)
Appl. No.: 599341
Filed: April 12, 1984

[USPTO Record]


Patenting ABC 

General Information Concerning Patents.
Excerpted from General Information Concerning Patents print brochure
USPTO Web site. last modified 4 April 2002
[FullText at USPTO]


Frequently Asked Questions about Patents and trademarks.
General Information Services Division
USPTO Web site. last modified 29 December 2002
[FullText at USPTO]


Patenting basic research: myths and realities.
Kirschenbaum SR.
Nature Neurosci. Nov 2002 5 Suppl: p. 1025-7
[PubMed] [FullText] [Authors contact]


Fine Tuning: Start a Business, Don't Sell Out.
Portman S.
The Scientist 24 Feb 2003 17(4): p. 53
[FullText] [Authors contact]


IP Policies and Serving the Public.
Beachy RN.
Science 24 Jan 2003 299: p. 473
[Abstract/FullText] [Authors contact]


Science and the law: Working Through the Patent Problem.
Walsh JP, Arora A, Cohen WM.
Science 14 Feb 2003 299: p. 1021
[Abstract/FullText] [Authors contact]


Patents in news 

Intellectual property: Judge Turns Rochester's Golden Patent Into Lead.
Malakoff D.
Science 14 Mar 2003 299: p. 1638-9
[Abstract/FullText] [Authors contact]


Patents and the Research Exemption.
Resnik D.
Science 7 Feb 2003 299: p. 821-2
[Abstract/FullText] [Authors contact]


Researchers caught in dispute over transgenic mice patents.
Dalton R.
Nature 23 March 2000 404: p. 319-20
[PubMed] [FullText]

Follow up coverage (3 items):

Mayo and the mouse.
Younkin SG, Stoddard S.
Nature 20 April 2000 404: p. 809
[PubMed] [FullText]
 

Patent suit on Alzheimer's mouse rejected.
Dalton R.
Nature 29 June 2000 405: p. 989
[PubMed] [FullText]

...but controversy over rights lingers on.
Dalton R.
Nature 29 June 2000 405: p. 989
[FullText]


Watch original NoL research published in other journals. Click here.


HOME ABOUT GUESTBOOK RECENT CONTENT SUBJECT COLLECTIONS PUBLISH WITH US
Copyright © 2002-2004 by the Neurobiology of Lipids, ISSN 1683-5506